ACTRN12619000122156尚未招募未知
Function of Implanted Glucose Sensor – High Definition Trial in type 1 diabetes
St Vincent's Hospital Melbourne0 个研究点目标入组 6 人开始时间: 2019年1月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •* Type 1 diabetes mellitus for at least 5 years
- •* c-peptide <150pmol/L
- •* HbA1c <10%
- •* BMI less than or equal to 35kg/m2
排除标准
- •* Serious chronic illness
- •* Use of paracetamol during the trial
研究者
相似试验
已完成
不适用
Function of Implanted Glucose Sensor 2Diabetes MellitusNCT02345967GlySens Incorporated20
已完成
不适用
Sensor for Measuring the blood glucose level as input for the ARtificial pancreas: a sensor validation Trial.Diabetes type 110018424NL-OMON49011Inreda Diabetic B.V.10
已完成
不适用
Continuous Glucose Monitoring by subcutaneous measurement compared to frequent point of care measurement by Accu Chek in critically ill patients; a randomized controlled trial (RESCUEII).sugar disease10018424diabetes mellitusNL-OMON34507Onze Lieve Vrouwe Gasthuis178
招募中
不适用
sability of Subcutaneous Continuous Glucose Monitoring in Critically Ill Patients.Blood glucose monitoring, critically ill patientsNL-OMON29113Academic Medical Center50
招募中
不适用
se of a real time continuous glucose monitoring system (RT-CGMS) in type 1 diabetes patients on continuous intraperitoneal insulin infusion (CIPII). A feasibility study.diabetesblood glucose regulation10018424NL-OMON31251Isala Klinieken12